Article

Vitamin Deficiency in Rheumatic Diseases

According to a team of researchers, nearly three-quarters of the patients seen at the South Infirmary-Victoria University Hospital rheumatology clinic of Cork City, Ireland, (SIVUH) have a vitamin D deficiency.

According to a team of researchers, nearly three-quarters of the patients seen at the South Infirmary-Victoria University Hospital rheumatology clinic of Cork City, Ireland, (SIVUH) have a vitamin D deficiency. SIVUH’s rheumatology clinic specializes primarily on diseases affecting the joints, muscles, bones, and tendons.

Muhammad Haroon, MD, and associates at SIVUH assessed the occurrence of vitamin D deficiency in all new patients seen at the clinic in the spring of 2007. The research team's findings were reported at the European Union League Against Rheumatism 2008 meeting in Paris.

Vitamin D is a fat-soluble vitamin that is naturally present in very few foods and available as a dietary supplement. It is also produced when ultraviolet (UV) rays from sunlight strike the skin and trigger vitamin D synthesis. Rheumatic disease affects the heart, bones, joints, kidney, skin and lung, so the presence of vitamin D is rather pertinent to this treatment area.

Of 264 patients seen during the six-month study, 231 agreed to have their levels of vitamin D measured and other related tests performed. Analysis of test results and other data revealed that 162 patients (70 percent) had low vitamin D levels and 26 percent had a severe deficiency. Little difference was seen in the percentage of younger and older patients who were deficient. Severe vitamin D deficiency affected a significant percentage of patients with a variety of conditions, including inflammatory joint diseases, rheumatism, arthritis, backache, and osteoporosis.

According to comments made by Haroon in the study, chronic severe vitamin D deficiency increases the risk of the bone-thinning disease osteoporosis and the bone-softening disease osteomalacia, while a mild-to-moderate deficiency may contribute to non-specific rheumatic complaints.

Related Videos
John Stone, MD, MPH: Continuing Progress With IgG4-Related Disease Research
Philip Conaghan, MBBS, PhD: Investigating NT3 Inhibition for Improving Osteoarthritis
Rheumatologists Recognize the Need to Create Pediatric Enthesitis Scoring Tool
Presence of Diffuse Cutaneous Disease Linked to Worse HRQOL in Systematic Sclerosis
Alexei Grom, MD: Exploring Safer Treatment Options for Refractory Macrophage Activation Syndrome
Jack Arnold, MBBS, clinical research fellow, University of Leeds, Leeds Institute of Rheumatic and Musculoskeletal Medicine
John Tesser, MD, Adjunct Assistant Professor of Medicine, Midwestern University, and Arizona College of Osteopathic Medicine, and Lecturer, University of Arizona Health Sciences Center, and Arizona Arthritis & Rheumatology Associates
Gaith Noaiseh, MD: Nipocalimab Improves Disease Measures, Reduces Autoantibodies in Sjogren’s
Laure Gossec, MD, PhD: Informing Physician Treatment Choices for Psoriatic Arthritis
Søren Andreas Just, MD, PhD: Developing AI to Mitigate Rheumatologist Shortages for Disease Assessment
© 2024 MJH Life Sciences

All rights reserved.